What is Axtria?
Founded in 2010 by Jassi Chadha, Axtria provides enterprise-grade, cloud-based software solutions tailored for the life sciences industry. By integrating advanced analytics into existing customer ecosystems, the firm enables organizations to optimize product commercialization, enhance sales performance, and improve healthcare outcomes across more than 75 countries. Axtria operates at the intersection of big data, cloud computing, and life sciences, positioning itself as a critical infrastructure partner for global healthcare enterprises seeking to digitize their commercial operations.
How much funding has Axtria raised?
Axtria has raised a total of $377.8M across 10 funding rounds:
Private Equity
$4.3M
Series A
$2.5M
Private Equity
$4.8M
Private Equity
$5.6M
Multiple Rounds
$55.6M
Debt
$5M
Private Equity
$150M
Private Equity
$150M
Private Equity (2009): $4.3M, investors not publicly disclosed
Series A (2010): $2.5M led by Sequoia Capital India
Private Equity (2013): $4.8M, investors not publicly disclosed
Private Equity (2014): $5.6M, investors not publicly disclosed
Series B (2015): $5.6M, investors not publicly disclosed
Private Equity (2015): $20M, investors not publicly disclosed
Series C (2015): $30M led by Helion Ventures
Debt (2020): $5M supported by PPP
Private Equity (2021): $150M featuring Bain Capital Tech Opportunities
Private Equity (2021): $150M backed by Bain Capital Tech Opportunities
Key Investors in Axtria
Bain Capital Tech Opportunities
A specialized investment arm of Bain Capital focusing on growth-stage technology companies that demonstrate significant potential for market disruption and operational scale.
Helion Ventures
A multi-stage, India-focused venture fund managing over $600 million, targeting technology-powered businesses and consumer services across various high-growth sectors.
Sequoia Capital India
A premier venture capital firm with a long-term investment horizon, known for partnering with entrepreneurs to build global market leaders across venture, growth, and late-stage opportunities.
What's next for Axtria?
With the recent influx of capital, Axtria is well-positioned to accelerate its product innovation roadmap and expand its global footprint. The company is expected to leverage these resources to deepen its penetration in emerging markets and enhance its proprietary analytics platform. As the life sciences sector continues to undergo rapid digital transformation, Axtria's focus on scalable, data-driven decision-making tools will likely remain a key driver of its long-term market leadership and enterprise value creation.
See full Axtria company page
